Endothelial nitric oxide synthase: The Cinderella of inflammation?

Trends in Pharmacological Sciences

Volumn 24, Issue 2, 2003, Pages 91-95

  Cirino, Giuseppe ^a   Fiorucci, Stefano ^c   Sessa, William C ^b  

^a Dipto di Farmacologia Sperimentale   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ISOENZYME; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; WORTMANNIN;

BLOOD VESSEL PERMEABILITY; ENZYME REGULATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

EID: 0037304922     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)00049-4     Document Type: Review

References (44)

1. Nathan C., Xie Q.-W. Nitric oxide synthase: roles, tolls and controls. Cell. 78:1994;915-918.
2. Alderton W.K., et al. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
3. Bernier S.G. Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with endothelial nitric-oxide synthase. J. Biol. Chem. 275:2000;30707-30715.
4. Venema J. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem. Biophys. Res. Commun. 226:1996;703-710.
5. Ju H., et al. Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric oxide synthase. J. Biol. Chem. 273:1998;24025-24029.
6. Papapetropoulos A., et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100:1997;3131-3139.
7. Simoncini T., et al. Genomic and nongenomic mechanisms of nitric oxide synthesis induction in endothelial cells by a fourth generation selective estrogen modulator. Endocrinology. 143:2002;2052-2061.
8. Sessa W.C., et al. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74:1994;349-353.
9. Davis M.E., et al. Shear stress regulates endothelial nitric oxide synthase expression through cSrc by divergent signaling pathways. Circ. Res. 89:2001;1073-1080.
10. Lee Y., Shin T. Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. J. Neuroimmunol. 126:2002;78-85.
11. Fulton D., et al. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 299:2001;818-824.
12. Fulton D., et al. Regulation of endothelium derived nitric oxide production by protein kinase Akt. Nature. 399:1999;597-601.
13. Dimmeler S., et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 399:1999;601-605.
14. Garcia-Cardena G., et al. Dissecting the interactions between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J. Biol. Chem. 272:1997;25437-25470.
15. Bucci M., et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 6:2000;1362-1367.
16. Razani B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276:2001;38121-38138.
17. Razani B., Lisanti M.P. Caveolin deficient mice: insights into caveolar function and human disease. J. Clin. Invest. 108:2001;1553-1561.
18. Schubert W., et al. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 277:2002;40091-40098.
19. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc. Natl. Acad. Sci. U. S. A. 87:1990;682-685.
20. Forstermann U., et al. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1788-1792.
21. Garcia-Cardena G., et al. Dynamic activation of endothelial nitric oxide synthase by hsp90. Nature. 392:1998;821-824.
22. Gratton J.P., et al. Reconstitution of an endothelial nitric oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin-stimulated displacement of eNOS from caveolin-1. J. Biol. Chem. 275:2000;22268-22272.
23. Russell K.S., et al. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effect on calcium sensitivity and NO release. J. Biol. Chem. 275:2000;5026-5030.
24. Pratt W.B. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu. Rev. Pharmacol. Toxicol. 37:1997;297-326.
25. 2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J. Biol. Chem. 276:2001;32663-32669.
26. Pritchard K.A. Jr, et al. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J. Biol. Chem. 276:2001;17621-17624.
27. Fontana J., et al. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase an NO release. Circ. Res. 90:2002;866-873.
28. Michel T. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6252-6256.
29. Corson M.A., et al. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res. 79:1996;984-991.
30. Garcia-Cardena G., et al. Endothelial nitric oxide is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271:1996;27237-27240.
31. Gallis B., et al. Identification of flow dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J. Biol. Chem. 274:1999;30101-30108.
32. Lefer D.J., et al. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am. J. Physiol. 276:1999;H1943-H1950.
33. Laroux F.S., et al. Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid. Redox Signal. 2:2000;391-396.
34. Grisham M.B., et al. Nitric oxide I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276:1999;G315-G321.
35. Cockrell A., et al. Role of inducible nitric oxide synthase in leukocyte extravasation in vivo. Biochem. Biophys. Res. Commun. 257:1999;684-686.
36. Fukumura D., et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2604-2609.
37. Morales-Ruiz M., et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ. Res. 86:2000;892-896.
38. Isner J.M. Tissue response to ischemia: local and remote responses for preserving perfusion of ischemic muscle. J. Clin. Invest. 106:2000;615-619.
39. Billecke S.S., et al. Hsp90 is required for heme binding and activation of apo-neuronal nitric-oxide synthase: geldanamycin-mediated oxidant generation is unrelated to any action of hsp90. J. Biol. Chem. 277:2002;20504-20509.
40. Bucci M., et al. Geldanamycin, an inhibitor of heat shock protein 90 (hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br. J. Pharmacol. 131:2000;13-16.
41. Zeng G., Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98:1996;894-898.
42. Michel B.J., et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9:1999;845-848.
43. Dedio J., et al. NOSIP a novel modulator of nitric oxide synthase activity. FASEB J. 15:2001;79-89.
44. Cao S., et al. Direct interaction between endothelial nitric oxide synthase and dynamin-2: implications for nitric oxide functions. J. Biol. Chem. 276:2001;14249-14256.